CTC 15 %w/w Premix for Medicated Feed

País: Irlanda

Idioma: anglès

Font: HPRA (Health Products Regulatory Authority)

ingredients actius:

Chlortetracycline hydrochloride

Disponible des:

Univet Limited

Codi ATC:

QJ01AA03

Designació comuna internacional (DCI):

Chlortetracycline hydrochloride

Dosis:

15 percent weight/weight

formulario farmacéutico:

Premix for medicated feeding stuff

tipo de receta:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupo terapéutico:

Cattle

Área terapéutica:

chlortetracycline

indicaciones terapéuticas:

Antibacterial

Estat d'Autorització:

Authorised

Data d'autorització:

2006-06-23

Fitxa tècnica

Health Products Regulatory Authority
11 February 2020
CRN009KKY
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
CTC 15 %w/w Premix for Medicated Feed
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains
ACTIVE SUBSTANCE
Chlortetracycline hydrochloride 150 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Premix for Medicated Feed.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Calves (less than 6 months of age) and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Calves:
The product is indicated as an aid in the treatment of respiratory
disease in calves caused by _Pasteurella spp_., sensitive to
chlortetracycline.
Pigs:
The product is indicated as an aid in the treatment of respiratory
disease in pigs caused by micro-organisms sensitive to
chlortetracycline.
4.3 CONTRAINDICATIONS
Do not use in adult ruminants, dairy cows and veal calves.
Do not use in animals with known hypersensitivity to the active
substance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the
bacteria isolated from the animal. If this is not possible,
therapy should be based on local (regional, farm level)
epidemiological information about susceptibility of the target
bacteria.
Inappropriate use of the product may increase the prevalence of
bacteria resistant to chlortetracycline and may decrease the
effectiveness of treatment with related substances, due to the
potential for cross-resistance.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
When incorporating into feed, care must be taken not to inhale any
dust. It is recommended that a face mask be worn during
the dispensing and mixing of the product. Avoid skin contact when
handling this product. Wash hands and all exposed skin at
the end of the operation.
Health Products Regulatory Authority
11 February 2020
CRN009KKY
Page